StockData
iSpecimen Inc. logo

iSpecimen Inc. (ISPC) income statement

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.60−0.01 (-1.45%)

Close on Nov 17, 2026Market cap $1.50MP/E –Yield –

iSpecimen Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
-98.0%
Operating margin
-2020.0%
Net margin
-2449.0%
Return on equity, FY2025
-327.8%

Financial strength

Current ratio
0.82
Debt to equity
–
Debt to assets
–
Cash to current liabilities
80.6%

Valuation

P/E ratio
–
Price to sales
3.22
Price to book
0.86
Dividend yield
–

See a number that looks wrong?